Middle east

Israeli Study: Pfizer Vaccine Less Effective Against Delta Variant

A preliminary study by Israel’s Ministry of Health found that amid the spread of the coronavirus’s Delta variant

A preliminary study by Israel’s Ministry of Health found that amid the spread of the coronavirus’s Delta variant, the Pfizer-BioNTech COVID-19 vaccine is only 64 percent effective (Times of Israel) in preventing symptomatic illness. When the Delta variant was less prevalent in Israel in May, the vaccine was 94 percent effective.

Related Articles

Leave a Reply

Back to top button